Skip to main content

Trinity Biotech PLC (TRIB)

NASDAQ: TRIB · IEX Real-Time Price · USD
2.09
+0.06 (2.96%)
After-hours:Oct 15, 2021 4:48 PM EDT
2.03
-0.15 (-6.88%)
At close: Oct 15, 4:00 PM
Market Cap42.43M
Revenue (ttm)101.98M
Net Income (ttm)-6.39M
Shares Out20.90M
EPS (ttm)-0.09
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume125,654
Open2.15
Previous Close2.18
Day's Range1.98 - 2.17
52-Week Range1.75 - 6.82
Beta1.69
AnalystsStrong Buy
Price Target7.00 (+244.8%)
Est. Earnings Daten/a

About TRIB

Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the United States, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other ...

IndustryHealth Care Equipment & Supplies
Founded1992
Employees543
Stock ExchangeNASDAQ
Ticker SymbolTRIB
Full Company Profile

Financial Performance

In 2020, TRIB's revenue was $101.98 million, an increase of 12.77% compared to the previous year's $90.44 million. Losses were -$6.39 million, -77.91% less than in 2019.

Financial Statements

Analyst Forecast

According to one analyst, the rating for TRIB stock is "Strong Buy" and the 12-month stock price forecast is 7.00.

Price Target
$7.00
(244.83% upside)
Analyst Consensus: Strong Buy

News

Trinity Biotech Announces Results for Q2, 2021

DUBLIN, Ireland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...

1 month ago - GlobeNewsWire

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2021 Financial Results

Conference Call Scheduled for September 9, 2021 at 11:00 am EASTERN Conference Call Scheduled for September 9, 2021 at 11:00 am EASTERN

1 month ago - GlobeNewsWire

Trinity Biotech Provides A Business Development Update For Q2 2021

DUBLIN, Ireland, July 16, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) provides a business development update for Q2 2021.

3 months ago - GlobeNewsWire

Trinity Biotech Announces Results for Q1, 2021

DUBLIN, Ireland, May 25, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, t...

4 months ago - GlobeNewsWire

Trinity Biotech plc to Announce First Quarter Fiscal Year 2021 Financial Results

Conference Call Scheduled for May 25, 2021 at 11:00 am EASTERN Conference Call Scheduled for May 25, 2021 at 11:00 am EASTERN

4 months ago - GlobeNewsWire

Top Penny Stocks For Your May Watchlist? Check These 5 Out

Looking for penny stocks to buy in May 2021? Here's some watchlist inspiration The post Top Penny Stocks For Your May Watchlist?

Other symbols:AHPIALNAPLINRELI
5 months ago - PennyStocks

Trinity Biotech Announces Quarter 4 and Fiscal Year 2020 Financial Results

DUBLIN, Ireland, March 25, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...

6 months ago - GlobeNewsWire

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2020 Financial Results

Conference Call Scheduled for March 25, 2021 at 11:00 am EASTERN Conference Call Scheduled for March 25, 2021 at 11:00 am EASTERN

6 months ago - GlobeNewsWire

5 Irish Stocks To Buy For St. Patrick's Day

For many people, St. Patrick's Day means a corned beef and cabbage dinner, a pint of Guinness and watching “The Quiet Man” for the 100th time. For investors seeking to add a breath of fresh Eire in thei...

Other symbols:ACNAERRYAAY
6 months ago - Benzinga

Trinity Biotech Announces CE Mark of its Covid-19 IgG ELISA Antibody Test

DUBLIN, Ireland, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved CE Mark approval and registration for its Covid-19 IgG ELISA antibody test, the Captia™ SARS-CoV-2 IgG ...

9 months ago - GlobeNewsWire

Is Trinity Biotech plc (TRIB) A Good Stock To Buy?

Is Trinity Biotech plc (NASDAQ:TRIB) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investor...

10 months ago - Insider Monkey

Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q3 2020 Results - Earnings Call Transcript

Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q3 2020 Results - Earnings Call Transcript

10 months ago - Seeking Alpha

Trinity Biotech Announces Results for Q3, 2020

DUBLIN, Ireland, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, ...

10 months ago - GlobeNewsWire

Trinity Biotech plc to Announce Third Quarter 2020 Financial Results

Conference Call Scheduled for November 17, 2020 at 11:00 am EASTERN Conference Call Scheduled for November 17, 2020 at 11:00 am EASTERN

11 months ago - GlobeNewsWire

Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q2 2020 Results - Earnings Call Transcript

Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q2 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Trinity Biotech Announces Results for Q2, 2020

DUBLIN, Ireland, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...

1 year ago - GlobeNewsWire

Trinity Biotech announces EUA submission for Covid-19 ELISA Antibody test

DUBLIN, Ireland, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...

1 year ago - GlobeNewsWire

Trinity Biotech plc to Announce Second Quarter 2020 Financial Results

Conference Call Scheduled for August 25, 2020 at 11:00am EASTERN Conference Call Scheduled for August 25, 2020 at 11:00am EASTERN

1 year ago - GlobeNewsWire

Why Trinity Biotech's Stock Is Trading Lower Today

Trinity Biotech (NASDAQ: TRIB) shares are trading lower on Monday after the company's subsidiary Primus Corp announced it received an FDA warning letter following an inspection of Kansas City Manufactur...

1 year ago - Benzinga

Trinity Biotech subsidiary, Primus Corporation Receives FDA Warning Letter

DUBLIN, Ireland, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...

1 year ago - GlobeNewsWire

Trinity Biotech's (TRIB) CEO Ronan O'Caoimh on Q1 2020 Results - Earnings Call Transcript

Trinity Biotech's (TRIB) CEO Ronan O'Caoimh on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Trinity Biotech Announces Results for Q1, 2020

DUBLIN, Ireland, May 27, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...

1 year ago - GlobeNewsWire

Trinity Biotech plc's (TRIB) CEO Ronan O'Caoimh on Q4 2019 Results - Earnings Call Transcript

Trinity Biotech plc's (TRIB) CEO Ronan O'Caoimh on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

What Trinity Bio Brings to the Fight Against COVID-19

Trinity Biotech PLC (NASDAQ: TRIB) released its fiscal fourth-quarter financial results on Tuesday morning, but that wasn’t what propelled the stock afterward.

1 year ago - 24/7 Wall Street

Penny Stocks to Buy Using Technical Analysis for March 2020

Penny stocks can be dangerous, particularly in this economic environment – so quick thinking and stop losses will be your best friends.

Other symbols:BNTCSUPV
1 year ago - Investopedia